Can we afford to pay? The bioVision 2001 summit in France examined the impact of biotechnology in the developed and the Third World, and the cost of inaction when addressing some of humankind's most pressing problems.
A
A
Moore
D001709:Biotechnology / Q000191:economics / Q000639:trends*; D003906:Developing Countries; D005544:Forecasting; D005602:France; D005818:Genetic Engineering; D015894:Genome, Human; D006801:Humans; D012106:Research